Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,412,262
+$161,182 QoQ
Shares Held
40,998
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.35%
of 13F equity value
Holder Rank
#1,087
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHULHOFF & CO INC holds $28,075,111 across 8 Drug Manufacturers - General names. JNJ ranks #1 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
40,998 | $10,412,262 | |
| 2 | ABBV |
AbbVie Inc.
|
26,880 | $6,764,083 | |
| 3 | LLY |
ELI LILLY & Co
|
4,825 | $5,787,250 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,263 | $1,575,795 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,914 | $1,205,064 | |
| 6 | PFE |
Pfizer Inc
|
45,453 | $1,094,508 | |
| 7 | NVS |
Novartis AG
|
6,053 | $948,626 | |
| 8 | AMGN |
Amgen Inc
|
794 | $287,523 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,412,262 | 40,998 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,251,080 | 41,937 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,690,037 | 41,991 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,803,586 | 42,086 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,474,919 | 42,389 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $7,126,642 | 42,973 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,225,891 | 43,050 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $7,063,060 | 43,583 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $6,357,813 | 43,499 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,048,788 | 44,559 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $6,997,657 | 44,645 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,956,885 | 44,667 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,942,973 | 47,988 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $7,487,275 | 48,305 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $8,620,520 | 48,800 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,018,525 | 49,085 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $8,494,386 | 47,853 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $8,449,971 | 47,678 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $8,231,546 | 48,118 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $7,867,957 | 48,718 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $8,113,939 | 49,253 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $8,102,948 | 49,303 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $7,494,120 | 47,618 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $7,176,164 | 48,201 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $6,778,506 | 48,201 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $6,605,804 | 50,376 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||